EP4125374A1 - Sterilizing solution - Google Patents

Sterilizing solution

Info

Publication number
EP4125374A1
EP4125374A1 EP21717516.5A EP21717516A EP4125374A1 EP 4125374 A1 EP4125374 A1 EP 4125374A1 EP 21717516 A EP21717516 A EP 21717516A EP 4125374 A1 EP4125374 A1 EP 4125374A1
Authority
EP
European Patent Office
Prior art keywords
essential oil
sterilizing solution
volume
mixture
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21717516.5A
Other languages
German (de)
French (fr)
Inventor
Giulio RAPETTI MOGOL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP4125374A1 publication Critical patent/EP4125374A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/18—Vapour or smoke emitting compositions with delayed or sustained release
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/06—Coniferophyta [gymnosperms], e.g. cypress
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/24—Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/28—Myrtaceae [Myrtle family], e.g. teatree or clove
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus

Definitions

  • the present invention concerns a sterilizing solution.
  • the present invention concerns a sterilizing solution of the air of a given environment, which can be used for the treatment of diseases such as acute nasopharyngitis, flu, asthma, and others.
  • these systems and products have the aim of eliminating bacteria, viruses and other pathogens from the air of the affected environment.
  • Some of these sterilization systems use so-called germicidal ultraviolet radiation, which modifies the DNA or RNA of microorganisms and thus prevents them from reproducing or being harmful.
  • the technical aim of the present invention is to improve the state of the art in the field of environment hygienization and sterilization.
  • Another object of the present invention is to make a sterilizing solution available that makes as much use as possible of active principles of natural derivation.
  • a further object of the present invention is to provide a chemical-free sterilizing solution.
  • Yet another object of the present invention is to provide a sterilizing solution that can be produced in a simple and economical way.
  • the sterilizing solution to sterilize the air of a given environment, comprises an aqueous solution, suitable for being diffused by atomisation in the above mentioned environment, comprising a mixture of eucalyptol, essential oil of eucalyptus radiata, essential oil of eucalyptus globulus , essential oil of ravensara, essential oil of niaouli , essential oil of pinus sylvestris.
  • an air sterilization device which comprises at least one diffuser suitable for nebulizing the aforementioned sterilizing solution in the air of a specific environment to be sterilized.
  • the sterilizing solution according to the present invention when diffused by nebulization in the air of a certain environment, is particularly indicated and effective in the treatment of diseases, mainly of the respiratory type, such as acute nasopharyngitis (cold), flu, asthma, and others.
  • diseases mainly of the respiratory type, such as acute nasopharyngitis (cold), flu, asthma, and others.
  • the present invention highlights the particular effectiveness, as an active principle, of the mixture of eucalyptol, essential oil of eucalyptus radiata, essential oil of eucalyptus globulus , essential oil of ravensara, essential oil of niaouli , essential oil of pinus sylvestris.
  • the solution according to the present invention is therefore completely harmless, i.e. completely non-toxic, and can be used, without any risk, even in the presence of people who normally do not tolerate certain chemical substances present in sterilizing products/sy stems currently on the market.
  • the sterilizing solution is an aqueous solution of the mixture of the above substances.
  • the sterilizing solution according to the invention is an aqueous solution comprising the aforementioned mixture of substances in a concentration not exceeding 10% by volume.
  • the sterilizing solution according to the invention is an aqueous solution comprising the aforementioned mixture of substances in a concentration not exceeding 5% by volume.
  • the sterilizing solution is an aqueous solution comprising the aforementioned mixture of substances in a concentration between 3% and 4% by volume.
  • the mixture of substances present in the solution comprises eucalyptol in a concentration not exceeding 20% by volume.
  • the mixture of substances present in the solution comprises essential oil of eucalyptus radiata in a concentration comprised between 15% and 17% by volume (preferably, about 16% by volume).
  • the mixture of substances present in the solution comprises essential oil of eucalyptus globulus in a concentration comprised between 15% and 17% by volume (preferably, about 16% by volume).
  • Eucalyptus and eucalyptol have a remarkable balsamic, fluidifying and expectorant action of catarrhal secretions of the respiratory tract.
  • the mixture of substances present in the solution comprises essential oil of niaouli in a concentration comprised between 15% and 17% by volume (preferably, about 16% by volume).
  • the essential oil of niaouli has balsamic properties, therefore it fluidifies catarrhal secretions of the respiratory system and the ear-nose-throat area.
  • the mixture of substances present in the solution comprises essential oil of ravensara in a quantity comprised between 15% and 17% by volume (preferably, about 16% by volume).
  • the essential oil has disinfectant, anti-infective, antiviral properties.
  • the mixture of substances present in the solution comprises essential oil of pinus sylvestris in a quantity comprised between 15% and 17% by volume (preferably, about 16% by volume).
  • the essential oil of pinus sylvestris has an invigorating, expectorant and antiseptic action.
  • the aforesaid quantities can be obtained, in a very simple but at the same time accurate manner, by dosing each of the substances with the dropper.
  • the mixture was prepared with:
  • the present invention also relates to a device for sterilizing air.
  • the device according to the invention comprises at least one diffuser able to atomise the previously described sterilizing solution in the air of a given environment to be sterilized.
  • the diffuser can be of any known type, suitable for atomising a liquid solution in an environment (for example, but not necessarily, a closed environment).
  • the present invention also relates to a method for administering the previously described sterilizing solution.
  • administration in this case, the diffusion of the solution according to the invention in the air present in a given environment, which is to be sterilized or sanitized.
  • the method comprises a step of providing a diffuser, suitable for atomising the aforementioned solution in the environment to be sterilized or sanitized.
  • the tank of the diffuser can comprise 200 ml of the aforementioned sterilizing solution.
  • the method then includes a step of operating said diffuser so as to atomise said solution in the air of said environment to be sterilized, for an uninterrupted period of time between 1 hour and 3 hours.
  • the diffuser can be operated for an uninterrupted period of time of 1 hour, or 2 hours, or 3 hours. More in detail, in an embodiment of the invention, the diffuser can be activated, over 24 hours, for an uninterrupted period of 2 hours in the morning, an uninterrupted period of 2 hours in the afternoon, and an uninterrupted period of 3 hours at night.
  • the activation of the diffuser for given periods of time, separated by appropriate pauses, allows an optimal air sterilization/sanitization outcome to be obtained in the environment concerned, without creating any discomfort for individuals due to saturation, with consequent intense odour.
  • the sterilizing solution according to the present invention is an interesting and valuable alternative to products and systems currently widely available on the market, which comprise chemical substances of synthetic origin, which can generate unwanted and harmful side effects, especially, but not exclusively, in given subjects who suffer from given diseases.
  • the solution according to the invention comprising a mixture of essential oils, all of natural origin, ensures maximum tolerance by a much higher number of subjects than is actually the case using known products and systems.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)

Abstract

A sterilizing solution of the air of a given environment, comprising an aqueous solution, suitable for being diffused by atomisation in the above mentioned environment, comprising a mixture of eucalyptol, essential oil of eucalyptus radiata, essential oil of eucalyptus globulus , essential oil of ravensara, essential oil of niaouli, essential oil of pinus sylvestris.

Description

“STERILIZING SOLUTION”.
TECHNICAL FIELD OF THE INVENTION The present invention concerns a sterilizing solution.
More particularly, the present invention concerns a sterilizing solution of the air of a given environment, which can be used for the treatment of diseases such as acute nasopharyngitis, flu, asthma, and others.
DESCRIPTION OF THE PRIOR ART
On the market today there are many technologies, systems and products for environmental sterilization for the benefit of patients suffering from diseases, mainly of the respiratory type, such as acute nasopharyngitis (cold), flu, asthma, and others.
In particular, these systems and products have the aim of eliminating bacteria, viruses and other pathogens from the air of the affected environment.
Some of these sterilization systems use so-called germicidal ultraviolet radiation, which modifies the DNA or RNA of microorganisms and thus prevents them from reproducing or being harmful.
It is used in a variety of applications, for example the disinfection of food, water, and even air.
Despite their considerable effectiveness, these systems can be potentially dangerous for humans, as direct exposure of an individual can produce skin bums and, in some cases, even skin cancer; radiation can also be potentially very dangerous for the eyes and sight.
Other known systems carry out the atomisation of disinfectant chemical products (e.g. hydrogen peroxide, or others).
These systems are particularly effective against bacteria, as they act by destroying the cell membrane; however, they act, more than anything else, on the environment surfaces on which the disinfectant chemical product settles down. Older solutions involved the use of an atomizer containing phenic acid, formalin, or other substances with a strong antiseptic power. However, since direct inhalation of these substances is toxic to humans, in the past this solution was used to sterilize a given environment (typically a surgery, an operating room) without any people inside it, for a given period of time.
In our society, the need to limit and contain the negative effects of viral and bacterial infections, seasonal flu, and other predominantly respiratory diseases is strongly felt.
Such situations can sometimes grow into actual emergencies.
At the same time, there is an increasing focus on avoiding the use of chemical products, preferring substances of a completely natural origin.
OBJECTS OF THE INVENTION
The technical aim of the present invention is to improve the state of the art in the field of environment hygienization and sterilization.
Within such technical aim, it is an object of the present invention to provide a sterilizing solution effective in the treatment of diseases such as acute nasopharyngitis, flu, asthma, and others.
Another object of the present invention is to make a sterilizing solution available that makes as much use as possible of active principles of natural derivation.
A further object of the present invention is to provide a chemical-free sterilizing solution.
Yet another object of the present invention is to provide a sterilizing solution that can be produced in a simple and economical way.
This aim and these objects are all achieved by a sterilizing solution according to the attached claim 1.
The sterilizing solution, to sterilize the air of a given environment, comprises an aqueous solution, suitable for being diffused by atomisation in the above mentioned environment, comprising a mixture of eucalyptol, essential oil of eucalyptus radiata, essential oil of eucalyptus globulus , essential oil of ravensara, essential oil of niaouli , essential oil of pinus sylvestris.
The mixture of these substances and essential oils, in the respective concentrations indicated in the following description, appears to be effective in the destruction of pathogens such as viruses and bacteria, and also in improving the respiratory condition of individuals who are in the environment treated with the solution.
This aim and these objects are also achieved by an air sterilization device, which comprises at least one diffuser suitable for nebulizing the aforementioned sterilizing solution in the air of a specific environment to be sterilized.
Dependent claims refer to advantageous embodiments of the invention.
EMBODIMENTS OF THE INVENTION The sterilizing solution according to the present invention, when diffused by nebulization in the air of a certain environment, is particularly indicated and effective in the treatment of diseases, mainly of the respiratory type, such as acute nasopharyngitis (cold), flu, asthma, and others.
In this sense, according to the present invention, a particular mixture of substances, including some essential oils, all of natural origin, have proved to be particularly effective for the purposes of treatment.
More in detail, the present invention highlights the particular effectiveness, as an active principle, of the mixture of eucalyptol, essential oil of eucalyptus radiata, essential oil of eucalyptus globulus , essential oil of ravensara, essential oil of niaouli , essential oil of pinus sylvestris.
Considering that all the active principles of the sterilizing solution according to the present invention are of completely natural origin, all possible potentially toxic and/or harmful effects deriving from the use of substances of synthetic origin used in other products currently available on the market are eliminated or at least drastically reduced.
The solution according to the present invention is therefore completely harmless, i.e. completely non-toxic, and can be used, without any risk, even in the presence of people who normally do not tolerate certain chemical substances present in sterilizing products/sy stems currently on the market.
In an embodiment of the invention, the sterilizing solution is an aqueous solution of the mixture of the above substances.
In particular, the sterilizing solution according to the invention is an aqueous solution comprising the aforementioned mixture of substances in a concentration not exceeding 10% by volume.
More in detail, the sterilizing solution according to the invention is an aqueous solution comprising the aforementioned mixture of substances in a concentration not exceeding 5% by volume.
Even more in detail, the sterilizing solution is an aqueous solution comprising the aforementioned mixture of substances in a concentration between 3% and 4% by volume.
By way of example, to obtain the sterilizing solution according to the invention, about 7.5 ml of a mixture of substances (corresponding to about 210 drops) are dissolved in 200 ml of water.
According to another aspect of the invention, the mixture of substances present in the solution comprises eucalyptol in a concentration not exceeding 20% by volume. According to another aspect of the invention, the mixture of substances present in the solution comprises essential oil of eucalyptus radiata in a concentration comprised between 15% and 17% by volume (preferably, about 16% by volume). According to another aspect of the invention, the mixture of substances present in the solution comprises essential oil of eucalyptus globulus in a concentration comprised between 15% and 17% by volume (preferably, about 16% by volume). Eucalyptus and eucalyptol have a remarkable balsamic, fluidifying and expectorant action of catarrhal secretions of the respiratory tract.
According to another aspect of the invention, the mixture of substances present in the solution comprises essential oil of niaouli in a concentration comprised between 15% and 17% by volume (preferably, about 16% by volume).
The essential oil of niaouli has balsamic properties, therefore it fluidifies catarrhal secretions of the respiratory system and the ear-nose-throat area.
According to another aspect of the invention, the mixture of substances present in the solution comprises essential oil of ravensara in a quantity comprised between 15% and 17% by volume (preferably, about 16% by volume).
The essential oil has disinfectant, anti-infective, antiviral properties. According to another aspect of the invention, the mixture of substances present in the solution comprises essential oil of pinus sylvestris in a quantity comprised between 15% and 17% by volume (preferably, about 16% by volume).
The essential oil of pinus sylvestris has an invigorating, expectorant and antiseptic action.
In the practical preparation of the mixture, the aforesaid quantities can be obtained, in a very simple but at the same time accurate manner, by dosing each of the substances with the dropper.
More in detail, in an embodiment of the invention, by way of non-limiting example, the mixture was prepared with:
- 7 droppers filled with eucalyptol (7 ml), corresponding to 196 drops (approximately 19% by volume of the mixture);
- 6 droppers filled with eucalyptus radiata essential oil (6 ml), corresponding to 168 drops (approximately 16% by volume of the mixture);
- 6 droppers filled with eucalyptus globulus essential oil (6 ml), corresponding to 168 drops (approximately 16% by volume of the mixture);
- 6 droppers filled with ravensara essential oil (6 ml), corresponding to 168 drops (approximately 16% by volume of the mixture);
- 6 droppers filled with niaouli essential oil (6 ml), corresponding to 168 drops (approximately 16% by volume of the mixture);
- 6 droppers filled with pinus sylvestris essential oil (6 ml), corresponding to 168 drops (approximately 16% by volume of the mixture).
The present invention also relates to a device for sterilizing air.
The device according to the invention comprises at least one diffuser able to atomise the previously described sterilizing solution in the air of a given environment to be sterilized.
The diffuser can be of any known type, suitable for atomising a liquid solution in an environment (for example, but not necessarily, a closed environment).
The present invention also relates to a method for administering the previously described sterilizing solution. In particular, it is meant by administration, in this case, the diffusion of the solution according to the invention in the air present in a given environment, which is to be sterilized or sanitized.
The method comprises a step of providing a diffuser, suitable for atomising the aforementioned solution in the environment to be sterilized or sanitized.
Then, a step of filling the diffuser tank with a predetermined quantity of the sterilizing solution is provided.
For example, the tank of the diffuser can comprise 200 ml of the aforementioned sterilizing solution. The method then includes a step of operating said diffuser so as to atomise said solution in the air of said environment to be sterilized, for an uninterrupted period of time between 1 hour and 3 hours.
Preferably, the diffuser can be operated for an uninterrupted period of time of 1 hour, or 2 hours, or 3 hours. More in detail, in an embodiment of the invention, the diffuser can be activated, over 24 hours, for an uninterrupted period of 2 hours in the morning, an uninterrupted period of 2 hours in the afternoon, and an uninterrupted period of 3 hours at night.
The activation of the diffuser for given periods of time, separated by appropriate pauses, allows an optimal air sterilization/sanitization outcome to be obtained in the environment concerned, without creating any discomfort for individuals due to saturation, with consequent intense odour.
It has thus been seen how the invention achieves the intended purposes.
The sterilizing solution according to the present invention is an interesting and valuable alternative to products and systems currently widely available on the market, which comprise chemical substances of synthetic origin, which can generate unwanted and harmful side effects, especially, but not exclusively, in given subjects who suffer from given diseases. The solution according to the invention, comprising a mixture of essential oils, all of natural origin, ensures maximum tolerance by a much higher number of subjects than is actually the case using known products and systems.
At the same time, the use of substances and essential oils exclusively of natural origin makes it possible to obtain a solution that is simple and easy to prepare, and also at lower costs than providing drugs currently available on the market.
This invention has been described with reference to some of its specific embodiments.
It is understood that there may be other embodiments directly connected to the same core and inventive concept, which all fall within the scope of protection offered by the following claims.

Claims

1. Sterilizing solution of the air of a given environment, characterised in that it includes an aqueous solution, suitable for being diffused by atomisation in said environment, comprising a mixture of eucalyptol, essential oil of eucalyptus radiata, essential oil of eucalyptus globulus , essential oil of ravensara, essential oil of niaouli , essential oil of pinus sylvestris.
2. Sterilizing solution according to claim 1, wherein said aqueous solution comprises said mixture in a concentration not exceeding 10% by volume.
3. Sterilizing solution according to claim 2, wherein said aqueous solution comprises said mixture in a concentration not exceeding 5% by volume.
4. Sterilizing solution according to claim 3, wherein said aqueous solution comprises said mixture in a concentration between 3% and 4% by volume.
5. Sterilizing solution according to any one of the preceding claims, wherein said mixture contains eucalyptol in a concentration not exceeding 20% by volume.
6. Sterilizing solution according to any one of the preceding claims, wherein said mixture comprises eucalyptus radiata essential oil in a concentration between 15% and 17% by volume.
7. Sterilizing solution according to any one of the preceding claims, wherein said mixture comprises eucalyptus globulus essential oil in a concentration between 15% and 17% by volume.
8. Sterilizing solution according to any one of the preceding claims, wherein said mixture comprises niaouli essential oil in a concentration between 15% and 17% by volume.
9. Sterilizing solution according to any one of the preceding claims, wherein said mixture comprises ravensara essential oil in a concentration between 15% and 17% by volume.
10. Sterilizing solution according to any one of the preceding claims, wherein said mixture comprises pinus sylvestris essential oil in a concentration between 15% and 17% by volume.
11. Air sterilization device, comprising a diffuser suitable for atomising the sterilizing solution in the air of a given environment to be sterilized according to any one of claims 1-10.
12. Method of administration of the sterilizing solution according to one of claims 1-10, comprising the steps of providing a diffuser suitable for atomising said sterilizing solution in the environment to be sterilized; filling the tank of said diffuser with a predetermined quantity of said sterilizing solution; operating said diffuser so as to atomize said solution in the air of said environment, for an uninterrupted period of time ranging from 1 hour to 3 hours.
13. Method according to claim 12, wherein said diffuser is operated for an uninterrupted period of time of 1 hour, or 2 hours, or 3 hours.
14. Method according to claim 13, wherein said diffuser is activated, over 24 hours, for an uninterrupted period of 2 hours in the morning, an uninterrupted period of 2 hours in the afternoon, and an uninterrupted period of 3 hours at night.
EP21717516.5A 2020-03-30 2021-03-10 Sterilizing solution Pending EP4125374A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT202000006595 2020-03-30
PCT/IB2021/051985 WO2021198815A1 (en) 2020-03-30 2021-03-10 Sterilizing solution

Publications (1)

Publication Number Publication Date
EP4125374A1 true EP4125374A1 (en) 2023-02-08

Family

ID=71170729

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21717516.5A Pending EP4125374A1 (en) 2020-03-30 2021-03-10 Sterilizing solution

Country Status (2)

Country Link
EP (1) EP4125374A1 (en)
WO (1) WO2021198815A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2333450A (en) * 1998-01-23 1999-07-28 Marshtech International Ltd Anti-Snoring Compositions
EP1048293A1 (en) * 1999-04-23 2000-11-02 The School Of Pharmacy, University Of London Headlice treatment compositions
US7150888B1 (en) * 2000-04-03 2006-12-19 Inhalation, Inc. Methods and apparatus to prevent colds, influenzaes, tuberculosis and opportunistic infections of the human respiratory system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048953B2 (en) * 2000-04-03 2006-05-23 Inhalation, Inc. Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS)
FR2962333B1 (en) * 2010-07-12 2014-05-02 Oreal NON-RINSE COMPOSITION COMPRISING AT LEAST ONE 2-ALCOXY-4-ALKYLCETONE-PHENOL COMPOUND AND AT LEAST ONE ESSENTIAL OIL

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2333450A (en) * 1998-01-23 1999-07-28 Marshtech International Ltd Anti-Snoring Compositions
EP1048293A1 (en) * 1999-04-23 2000-11-02 The School Of Pharmacy, University Of London Headlice treatment compositions
US7150888B1 (en) * 2000-04-03 2006-12-19 Inhalation, Inc. Methods and apparatus to prevent colds, influenzaes, tuberculosis and opportunistic infections of the human respiratory system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021198815A1 *

Also Published As

Publication number Publication date
WO2021198815A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
El Meligy et al. Ozone therapy in medicine and dentistry: a review of the literature
CA2765696C (en) Solution containing hypochlorous acid and methods of using same
Koban et al. Synergistic effects of nonthermal plasma and disinfecting agents against dental biofilms in vitro
CA2761710C (en) Methods of treating or preventing influenza associated illness with oxidative reductive potential water solutions
CN111084199A (en) Preparation method of negative ion antibacterial liquid
JP2011019857A5 (en)
KR102127417B1 (en) Compositions for sterilization and disinfection using hydrogen peroxide
EP4125374A1 (en) Sterilizing solution
US20210177892A1 (en) Prevention and treatment of infectious disease using low concentration hypochlorous acid solutions
CN111357775A (en) Formula with air disinfection effect
US20220054539A1 (en) Disinfection and deodorizing of pap equipment using low concentration hypochlorous acid solutions
CN107929725A (en) A kind of environmentally friendly lysine polypeptide skin care thimerosal and its preparation process
CN115067354A (en) A kind of sanitation and environment disinfectant and its application
CN103933309A (en) Method for treating phthisis by inhaling atomized purple garlic liquid
TWM609458U (en) Sustained-release antibacterial structure
KR20220088066A (en) Portable unit removed bad flavor for sterilizing and deodorizing life space
CN106212542A (en) A kind of preparation method of veterinary Chinese medicine disinfectant
CN111956516A (en) Washing-free antibacterial fragrance composition and preparation method thereof
CN103110972A (en) Natural-fragrance air sterilization freshener
JP3085300U (en) Hemodiafiltration device that injects ozone into the human body
US20240350633A1 (en) Plasma-activated media for use thereof in the treatment of respiratory diseases
Bocci Preparation of Ozonated water and oil for the topical therapy–ozone as a drinking water disinfectant: ozone disinfection to prevent nosocomial infections
Bocklagea et al. Evaluation of Hypochlorous Acid Fogging: An Alternative Disinfection Method
US20060292196A1 (en) Formulation for obtaining a pharmaceutical composition, method for obtaining and use thereof
CN111744041A (en) Edible air antibacterial aromatic liquid and preparation method thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20221028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230529

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250630